tradingkey.logo
tradingkey.logo
Search

Acurx Pharmaceuticals Inc

ACXP
Add to Watchlist
1.440USD
+0.020+1.41%
Close 07-31 16:00ETQuotes delayed by 15 min
4.88MMarket Cap
LossP/E TTM

ACXP Balance Sheet

You can check out the annual or quarterly balance sheets of Acurx Pharmaceuticals Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Total equity
Cash, cash equivalents and short-term investments
99.29%9.25M
103.85%7.56M
2.50%5.91M
-4.66%6.06M
-47.94%4.64M
-50.41%3.71M
-18.29%5.76M
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-26.64%10.61M
-46.82%9.09M
321.68%11.08M
--12.96M
--14.46M
--17.10M
--2.63M
- Cash and cash equivalents
99.29%9.25M
103.85%7.56M
2.50%5.91M
-4.66%6.06M
-47.94%4.64M
-50.41%3.71M
-18.29%5.76M
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-26.64%10.61M
-46.82%9.09M
321.68%11.08M
--12.96M
--14.46M
--17.10M
--2.63M
Receivables
--56.31K
-5.30%48.42K
-58.71%40.21K
-21.36%40.21K
--0.00
-60.42%51.13K
--97.37K
--51.13K
--0.00
--129.16K
----
----
----
----
----
----
----
----
----
----
----
-Other receivables
--56.31K
-5.30%48.42K
-58.71%40.21K
-21.36%40.21K
--0.00
-60.42%51.13K
--97.37K
--51.13K
--0.00
--129.16K
----
----
----
----
----
----
----
----
----
----
----
Prepaid expenses
41.62%228.83K
-15.09%85.02K
28.81%158.20K
-68.22%53.52K
-14.01%161.57K
-5.34%100.12K
16.17%122.82K
87.24%168.41K
-9.05%187.91K
-60.08%105.78K
-68.70%105.72K
-23.03%89.94K
-13.72%206.60K
-10.28%264.95K
-36.33%337.81K
-66.08%116.86K
1599.58%239.45K
--295.30K
--530.58K
--344.55K
--14.09K
Other current assets
----
----
----
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Total current assets
98.52%9.54M
99.32%7.69M
2.05%6.11M
-6.42%6.16M
-47.24%4.81M
-49.96%3.86M
-16.42%5.98M
-28.75%6.58M
23.34%9.11M
-17.78%7.71M
-34.60%7.16M
0.29%9.24M
-34.77%7.39M
-29.25%9.38M
-26.98%10.95M
-47.20%9.21M
328.49%11.32M
--13.25M
--14.99M
--17.44M
--2.64M
Non-current assets
Other non-current assets
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--50.25K
----
----
----
----
--339.48K
Total non-current assets
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--50.25K
----
----
----
----
--339.48K
Total assets
98.52%9.54M
99.32%7.69M
2.05%6.11M
-6.42%6.16M
-47.24%4.81M
-49.96%3.86M
-16.42%5.98M
-28.75%6.58M
23.34%9.11M
-17.78%7.71M
-34.60%7.16M
-0.25%9.24M
-34.77%7.39M
-29.25%9.38M
-26.98%10.95M
-46.91%9.26M
279.71%11.32M
--13.25M
--14.99M
--17.44M
--2.98M
Liabilities
Current liabilities
-Other payables
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
Accrued expenses
1.32%2.52M
-25.44%2.41M
-25.33%2.46M
-17.68%2.59M
-19.68%2.49M
6.56%3.24M
2.74%3.30M
4.53%3.14M
50.86%3.10M
49.53%3.04M
173.07%3.21M
542.26%3.01M
228.01%2.06M
160.35%2.03M
67.95%1.18M
-74.30%468.12K
41.21%626.67K
--780.53K
--700.29K
--1.82M
--443.78K
Short-term debt and lease liabilities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--16.63K
Other current liabilities
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
Total current liabilities
1.31%2.53M
-25.35%2.42M
-25.63%2.47M
-17.81%2.59M
-19.81%2.49M
6.59%3.24M
2.96%3.32M
4.42%3.15M
49.96%3.11M
47.57%3.04M
172.69%3.22M
537.17%3.02M
227.63%2.07M
144.30%2.06M
65.92%1.18M
-75.30%473.88K
37.38%633.03K
--843.91K
--712.44K
--1.92M
--460.80K
Non-current liabilities
Long-term debt and lease liabilities
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--49.88K
-Long-term debt
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--49.88K
Other non-current liabilities
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Total non-current liabilities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--49.88K
Total liabilities
1.31%2.53M
-25.35%2.42M
-25.63%2.47M
-17.81%2.59M
-19.81%2.49M
6.59%3.24M
2.96%3.32M
4.42%3.15M
49.96%3.11M
47.57%3.04M
172.69%3.22M
537.17%3.02M
227.63%2.07M
144.30%2.06M
65.92%1.18M
-75.30%473.88K
23.96%633.03K
--843.91K
--712.44K
--1.92M
--510.68K
Shareholders' equity
Common equity
17.00%83.98M
18.58%80.56M
15.09%77.35M
15.56%75.28M
12.87%71.78M
17.36%67.94M
29.14%67.20M
27.22%65.15M
35.73%63.60M
25.96%57.89M
15.27%52.04M
26.05%51.21M
17.41%46.86M
17.96%45.96M
18.18%45.14M
16.74%40.62M
124.88%39.91M
--38.96M
--38.20M
--34.80M
--17.75M
Retained earnings
-10.79%-76.97M
-11.83%-75.29M
-14.21%-73.71M
-16.20%-71.72M
-20.62%-69.47M
-26.50%-67.32M
-34.17%-64.54M
-37.19%-61.72M
-38.64%-57.60M
-37.73%-53.22M
-35.96%-48.10M
-41.30%-44.99M
-42.18%-41.54M
-45.55%-38.64M
-47.90%-35.38M
-65.15%-31.84M
-91.28%-29.22M
---26.55M
---23.92M
---19.28M
---15.27M
Capital reserves
17.03%83.98M
18.60%80.55M
15.12%77.35M
15.59%75.28M
12.87%71.76M
17.36%67.92M
29.14%67.19M
27.23%65.13M
35.73%63.58M
25.96%57.87M
15.27%52.03M
26.05%51.19M
17.41%46.84M
17.96%45.94M
18.18%45.13M
16.74%40.61M
--39.90M
--38.95M
--38.19M
--34.79M
----
Total equity
203.42%7.01M
756.51%5.27M
36.53%3.64M
4.05%3.57M
-61.47%2.31M
-86.82%615.12K
-32.29%2.66M
-44.86%3.43M
12.94%6.00M
-36.20%4.67M
-59.70%3.93M
-29.24%6.22M
-50.31%5.31M
-41.06%7.32M
-31.62%9.76M
-43.40%8.79M
332.56%10.69M
--12.41M
--14.28M
--15.52M
--2.47M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

Which balance sheet metrics matter most when analyzing ACXP stock?

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Acurx Pharmaceuticals Inc Have?

In its most recent quarterly, Acurx Pharmaceuticals Inc had 9.25M in cash and cash equivalents.

How Much Shareholders' Equity Does Acurx Pharmaceuticals Inc Have?

Acurx Pharmaceuticals Inc reported 5.27M in total shareholders' equity as of the latest reported quarter.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.